Literature DB >> 30478290

Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.

Kuan-Ying A Huang1,2, Pramila Rijal3, Haihai Jiang4,5, Beibei Wang6,7,8, Lisa Schimanski3, Tao Dong3,6, Yo-Min Liu9, Pengxiang Chang10, Munir Iqbal10, Mu-Chun Wang11, Zhihai Chen8,12, Rui Song8,12, Chung-Chi Huang13, Jeng-How Yang14, Jianxun Qi4, Tzou-Yien Lin15,16, Ang Li7,8, Timothy J Powell3, Jia-Tsrong Jan9, Che Ma9, George F Gao17,18,19, Yi Shi20,21,22, Alain R Townsend23,24.   

Abstract

Little is known about the specificities and neutralization breadth of the H7-reactive antibody repertoire induced by natural H7N9 infection in humans. We have isolated and characterized 73 H7-reactive monoclonal antibodies from peripheral B cells from four donors infected in 2013 and 2014. Of these, 45 antibodies were H7-specific, and 17 of these neutralized the virus, albeit with few somatic mutations in their variable domain sequences. An additional set of 28 antibodies, isolated from younger donors born after 1968, cross-reacted between H7 and H3 haemagglutinins in binding assays, and had accumulated significantly more somatic mutations, but were predominantly non-neutralizing in vitro. Crystal structures of three neutralizing and protective antibodies in complex with the H7 haemagglutinin revealed that they recognize overlapping residues surrounding the receptor-binding site of haemagglutinin. One of the antibodies, L4A-14, bound into the sialic acid binding site and made contacts with haemagglutinin residues that were conserved in the great majority of 2016-2017 H7N9 isolates. However, only 3 of the 17 neutralizing antibodies retained activity for the Yangtze River Delta lineage viruses isolated in 2016-2017 that have undergone antigenic change, which emphasizes the need for updated H7N9 vaccines.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30478290     DOI: 10.1038/s41564-018-0303-7

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  21 in total

Review 1.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

2.  Evolution of the North American Lineage H7 Avian Influenza Viruses in Association with H7 Virus's Introduction to Poultry.

Authors:  Sungsu Youk; Christina Leyson; Mary Lea Killian; Mia Kim Torchetti; Dong-Hun Lee; David L Suarez; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2022-07-07       Impact factor: 6.549

3.  Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface.

Authors:  Jinhui Dong; Iuliia Gilchuk; Sheng Li; Ryan Irving; Matthew T Goff; Hannah L Turner; Andrew B Ward; Robert H Carnahan; James E Crowe
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

4.  Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy.

Authors:  Xiaoyi Zhu; Fei Yu; Yanling Wu; Tianlei Ying
Journal:  Antib Ther       Date:  2021-05-17

Review 5.  Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.

Authors:  William J Liu; Haixia Xiao; Lianpan Dai; Di Liu; Jianjun Chen; Xiaopeng Qi; Yuhai Bi; Yi Shi; George F Gao; Yingxia Liu
Journal:  Front Med       Date:  2021-04-16       Impact factor: 4.592

6.  Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.

Authors:  Kuan-Ying A Huang; Tiong Kit Tan; Ting-Hua Chen; Chung-Guei Huang; Ruth Harvey; Saira Hussain; Cheng-Pin Chen; Adam Harding; Javier Gilbert-Jaramillo; Xu Liu; Michael Knight; Lisa Schimanski; Shin-Ru Shih; Yi-Chun Lin; Chien-Yu Cheng; Shu-Hsing Cheng; Yhu-Chering Huang; Tzou-Yien Lin; Jia-Tsrong Jan; Che Ma; William James; Rodney S Daniels; John W McCauley; Pramila Rijal; Alain R Townsend
Journal:  PLoS Pathog       Date:  2021-02-26       Impact factor: 6.823

7.  Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.

Authors:  Mutsumi Ito; Seiya Yamayoshi; Kazushi Murakami; Kenji Saito; Atsuo Motojima; Kazunari Nakaishi; Yoshihiro Kawaoka
Journal:  Viruses       Date:  2019-02-11       Impact factor: 5.048

8.  Immune Escape Adaptive Mutations in the H7N9 Avian Influenza Hemagglutinin Protein Increase Virus Replication Fitness and Decrease Pandemic Potential.

Authors:  Pengxiang Chang; Joshua E Sealy; Jean-Remy Sadeyen; Sushant Bhat; Deimante Lukosaityte; Yipeng Sun; Munir Iqbal
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

9.  Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.

Authors:  Iuliia M Gilchuk; Sandhya Bangaru; Pavlo Gilchuk; Ryan P Irving; Nurgun Kose; Robin G Bombardi; Natalie J Thornburg; C Buddy Creech; Kathryn M Edwards; Sheng Li; Hannah L Turner; Wenli Yu; Xueyong Zhu; Ian A Wilson; Andrew B Ward; James E Crowe
Journal:  Cell Host Microbe       Date:  2019-11-19       Impact factor: 31.316

10.  Seroprevalence of H7N9 infection among humans: A systematic review and meta-analysis.

Authors:  Qiang Wang; Ke Xu; Weihua Xie; Liuqing Yang; Haiyan Chen; Naiyang Shi; Changjun Bao; Haodi Huang; Xuefeng Zhang; Yilan Liao; Hui Jin
Journal:  Influenza Other Respir Viruses       Date:  2020-03-10       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.